Fierce Biotech June 21, 2024
Researchers at Mass General Brigham found that artificial intelligence software like ChatGPT could help speed up the screening process to find patients eligible for clinical trials—though they cautioned that additional safeguards would be necessary.
Using a version of OpenAI’s GPT-4 program through Microsoft’s Azure cloud service, the researchers found that a tailored generative AI application was able to quickly comb through patient notes within electronic medical records and accurately identify those with heart failure who met the criteria for a study.
That trial, named COPILOT-HF, aims to determine if a virtual clinic approach can help remotely steer more patients onto guideline-recommended medication regimens for heart failure. The researchers designed a set of 13 prompts to help the program determine if...
Today's Sponsors
Today's Sponsor